BTG plc (LON:BTG) has earned an average recommendation of “Buy” from the ten analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is GBX 766.44 ($9.98).

Several equities analysts recently issued reports on the company. Numis Securities Ltd restated a “buy” rating and set a GBX 900 ($11.72) price target on shares of BTG plc in a research note on Thursday, July 13th. J P Morgan Chase & Co lowered their price target on BTG plc from GBX 790 ($10.29) to GBX 750 ($9.77) and set a “neutral” rating on the stock in a research note on Wednesday, May 17th. Shore Capital restated a “not rated” rating on shares of BTG plc in a research note on Thursday, July 13th. Deutsche Bank AG restated a “buy” rating and set a GBX 775 ($10.09) price target on shares of BTG plc in a research note on Thursday, May 18th. Finally, Panmure Gordon lowered their price target on BTG plc from GBX 809 ($10.54) to GBX 793 ($10.33) and set a “buy” rating on the stock in a research note on Monday, May 22nd.

In other BTG plc news, insider Rolf Soderstrom sold 129,514 shares of BTG plc stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of GBX 655 ($8.53), for a total transaction of £848,316.70 ($1,104,722.88).

COPYRIGHT VIOLATION NOTICE: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/08/btg-plc-lonbtg-receives-average-rating-of-buy-from-brokerages.html.

BTG plc (BTG) opened at 655.00 on Tuesday. The firm’s 50-day moving average price is GBX 675.25 and its 200-day moving average price is GBX 629.04. The company’s market cap is GBX 2.52 billion. BTG plc has a 12-month low of GBX 528.36 and a 12-month high of GBX 738.50.

About BTG plc

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Analyst Recommendations for BTG plc (LON:BTG)

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.